GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Human Metabolome Technologies Inc (TSE:6090) » Definitions » Research & Development

Human Metabolome Technologies (TSE:6090) Research & Development : 円0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Human Metabolome Technologies Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Human Metabolome Technologies's Research & Development for the three months ended in Dec. 2024 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was 円0 Mil.


Human Metabolome Technologies Research & Development Historical Data

The historical data trend for Human Metabolome Technologies's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Human Metabolome Technologies Research & Development Chart

Human Metabolome Technologies Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Jun20 Jun21 Jun22 Jun23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Human Metabolome Technologies Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Human Metabolome Technologies Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Human Metabolome Technologies  (TSE:6090) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Human Metabolome Technologies Research & Development Related Terms

Thank you for viewing the detailed overview of Human Metabolome Technologies's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Human Metabolome Technologies Business Description

Traded in Other Exchanges
N/A
Address
Yamagata Prefecture Kakuganji Water 246-2, Tsuruoka, JPN, 997-0052
Human Metabolome Technologies Inc is involved in the search and diagnosis of biomarkers and commercialization in the field of drug development.

Human Metabolome Technologies Headlines

No Headlines